Validity Of Turkish Version Of ABC Scale In Diabetes Mellitus Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04920279|
Recruitment Status : Recruiting
First Posted : June 9, 2021
Last Update Posted : June 9, 2021
|Condition or disease|
|Diabetes Mellitus Balance; Distorted Evaluations, Diagnostic Self|
Thirty patients with DM will be included according to the inclusion and exclusion criteria. All the participants will be evaluated by ABC form and Timed Up and Go Test (TUG). The Cumulative Illness Rating Scale (CIRS ) will be used for all the patients.
ABC scale is a self-assessment test with 16 items that helps assess balance impairments and falling risk, and it also investigates how confident people are while they are in some specific activities both indoors, and outdoors. Total score changes between 0-100.
The HbA1c values of all patients will be noted if a blood test will be performed in the last three months.
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Validity Of The Turkish Version Of Activities-Specific Balance Confidence Scale In Patients With Diabetes Mellitus|
|Actual Study Start Date :||June 11, 2018|
|Estimated Primary Completion Date :||December 31, 2021|
|Estimated Study Completion Date :||July 30, 2022|
The patients with diabetes mellitus
When patients with diabetes mellitus admitted to our outpatient clinic if they have inclusion criteria, we have used the ABC questionnaire. And we have done perform Time Up And Go Test twice respectively.
- Validity of the Turkish Version of Activities-specific Balance Confidence Scale in Patients With Diagnosis of the Diabetes Mellitus Before. [ Time Frame: In 2021 ]cross-sectional
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04920279
|Contact: Feride Sabirli, MDfirstname.lastname@example.org|
|Contact: Nurdan Paker, Profemail@example.com|
|Istanbul Physical Medicine Rehabilitation Training & Research Hospital||Recruiting|
|Istanbul, Turkey, 34173|
|Contact: Nurdan Paker, Prof firstname.lastname@example.org|
|Contact: Nurdan Paker email@example.com|
|Contact: İlhan Karacan|
|Principal Investigator:||Nurdan Paker, Prof||Istanbul Physical Medicine Rehabilitation Training and Research Hospital|